Intelligent Bio Solutions (NASDAQ:INBS) Stock Price Down 2.1% – Time to Sell?

Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) fell 2.1% during mid-day trading on Tuesday . The company traded as low as $1.39 and last traded at $1.43. 74,089 shares were traded during trading, a decline of 15% from the average session volume of 87,097 shares. The stock had previously closed at $1.46.

Intelligent Bio Solutions Stock Down 2.1 %

The company has a 50 day simple moving average of $1.51 and a 200-day simple moving average of $1.55.

Intelligent Bio Solutions (NASDAQ:INBS) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.70) earnings per share for the quarter, missing the consensus estimate of ($0.53) by ($0.17). The business had revenue of $872.29 million for the quarter. Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%. Equities research analysts forecast that Intelligent Bio Solutions Inc. will post -1.25 earnings per share for the current fiscal year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.